Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Bacon

Showing results (21-30 of 280) with videos related to

Pageof 28
Sort By:
Clinical and Experimental Immunology|January 1, 1988
A cellular deficiency in the rheumatoid one-way mixed lymphocyte reactionM Salmon, P A Bacon
Best Practice & Research. Clinical Rheumatology|July 27, 2001
New therapeutic aspects: haemopoietic stem cell transplantationP A Bacon, D Carruthers
British Journal of Rheumatology|November 1, 1995
How and when should combination therapy be used? The role of an anchor drugM Farr, P A Bacon
Agents and Actions|December 1, 1986
Abnormal populations of activated lymphocytes in the rheumatoid one-way MLRM Salmon, P A Bacon
Annals of the Rheumatic Diseases|May 1, 1987
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rashM Farr, P A Bacon
The Practitioner|May 3, 2000
Key developments in rheumatologyP A Bacon, M Allen
Scandinavian Journal of Rheumatology. Supplement|January 1, 1987
Modes of action of second-line agentsP A Bacon, M Salmon
Lancet (London, England)|March 13, 1982
Iron and rheumatoid diseaseD Blake, P A Bacon
Annals of the Rheumatic Diseases|September 1, 1972
Cellular hypersensitivity to salivary blood and liver in Sjogren's syndromeH Berry, P A Bacon
Current Opinion in Rheumatology|January 1, 1996
Clinical disease activity in systemic vasculitisA R Exley, P A Bacon
Pageof 28

Showing results (21-30 of 280) with videos related to

Sort By:
Pageof 28
Clinical and Experimental Immunology|January 1, 1988
A cellular deficiency in the rheumatoid one-way mixed lymphocyte reactionM Salmon, P A Bacon
Best Practice & Research. Clinical Rheumatology|July 27, 2001
New therapeutic aspects: haemopoietic stem cell transplantationP A Bacon, D Carruthers
British Journal of Rheumatology|November 1, 1995
How and when should combination therapy be used? The role of an anchor drugM Farr, P A Bacon
Agents and Actions|December 1, 1986
Abnormal populations of activated lymphocytes in the rheumatoid one-way MLRM Salmon, P A Bacon
Annals of the Rheumatic Diseases|May 1, 1987
Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rashM Farr, P A Bacon
The Practitioner|May 3, 2000
Key developments in rheumatologyP A Bacon, M Allen
Scandinavian Journal of Rheumatology. Supplement|January 1, 1987
Modes of action of second-line agentsP A Bacon, M Salmon
Lancet (London, England)|March 13, 1982
Iron and rheumatoid diseaseD Blake, P A Bacon
Annals of the Rheumatic Diseases|September 1, 1972
Cellular hypersensitivity to salivary blood and liver in Sjogren's syndromeH Berry, P A Bacon
Current Opinion in Rheumatology|January 1, 1996
Clinical disease activity in systemic vasculitisA R Exley, P A Bacon
Pageof 28